NCT07208136View on ClinicalTrials.gov

A Study of JMKX005425 in Patients With MSI-H/dMMR Advanced Solid Tumors

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions

Advanced Solid Tumors

Interventions

DRUG

JMKX005425

JMKX005425 administered orally.

Trial Locations (1)

100142

Beijing Cancer Hospital, Beijing

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Jemincare

INDUSTRY